Sigma-Aldrich Posts 2 Percent Revenue Growth for Q1 | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its first-quarter 2013 revenues increased 2 percent year over year led by sales gains for its SAFC business.

The St. Louis-based chemicals and research products firm had total revenues of $675 million for the three months ended March 31, compared to revenues of $665 million for the first quarter of 2012. It beat the consensus Wall Street estimate of $672.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.